Pierantonio Bevilacqua
- Cancer Research top 1%
- Breast Cancer Treatment Studies 16
- Oncology top 2%
- HER2/EGFR in Cancer Research 13
- Cancer-related Molecular Pathways 5
- Cancer Treatment and Pharmacology 5
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 5
- Molecular Biology top 5%
- Angiogenesis and VEGF in Cancer 8
- Otorhinolaryngology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 8
-
- Cardiovascular Effects of Exercise 4
Pierantonio Bevilacqua
55 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Cancer Research 1.5k
- Oncology 1.4k
- Immunology and Allergy 274
- Molecular Biology 1.9k
- Otorhinolaryngology 104
Countries citing papers authored by Pierantonio Bevilacqua
This map shows the geographic impact of Pierantonio Bevilacqua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierantonio Bevilacqua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierantonio Bevilacqua more than expected).
Fields of papers citing papers by Pierantonio Bevilacqua
This network shows the impact of papers produced by Pierantonio Bevilacqua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierantonio Bevilacqua. The network helps show where Pierantonio Bevilacqua may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pierantonio Bevilacqua, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Could past Chlamydial vascular infection promote the dissemination of Chlamydia pneumoniae to the brain? | 2013 | 12 |
| 2 | 2001 | 11 | |
| 3 | 2001 | 45 | |
| 4 | 1998 | 16 | |
| 5 | 1998 | 24 | |
| 6 | 1997 | 33 | |
| 7 | 1996 | 17 | |
| 8 | 1995 | 83 | |
| 9 | 1994 | 8 | |
| 10 | 1994 | 26 | |
| 11 | 1994 | 396 | |
| 12 | 1992 | 87 | |
| 13 | 1992 | 11 | |
| 14 | 1992 | 7 | |
| 15 | Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinomabreakdown → | 1992 | 1535 |
| 16 | 1991 | 11 | |
| 17 | 1990 | 21 | |
| 18 | 1989 | 35 | |
| 19 | 1988 | 96 | |
| 20 | [Possibilities and limitations of morphine analgesia in 377 cases]. | 1983 | 1 |
About Pierantonio Bevilacqua
Pierantonio Bevilacqua is a scholar working on Cancer Research, Oncology and Immunology and Allergy, having authored 56 papers that have together received 3.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (16 papers), HER2/EGFR in Cancer Research (13 papers), Angiogenesis and VEGF in Cancer (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Cancer-related Molecular Pathways (5 papers), Cancer Treatment and Pharmacology (5 papers), Cell Adhesion Molecules Research (5 papers) and Cardiovascular Effects of Exercise (4 papers). The work is most often cited by research in Cancer Research (1.5k citations), Oncology (1.4k citations) and Immunology and Allergy (274 citations). Pierantonio Bevilacqua has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Giampietro Gasparini, F. Pozza, Noel Weidner, S Meli, Elizabeth N. Allred, J Folkman, Dan H. Moore, Patrizia Boracchi, Sergio Maluta and Orazio Caffo. Their work appears in journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.